Laboratory Corporation of America Holdings

Common Name
Labcorp
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Employees
67,000
Ticker
LH
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemis...

Labcorp's Financial Statements Preview

Below are the financial statements of Labcorp, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024 as of 2024-12-31
2023 as of 2023-12-31
Assets
Current assets
Cash and cash equivalents
1,518.7a
536.8a
Accounts receivable, net
1,944.1a
1,913.3a
Unbilled services
152.9a
185.4a
Supplies inventory
493.2a
474.6a
Prepaid expenses and other
697.6a
655.3a
Total current assets
4,806.5a
3,765.4a
Property, plant and equipment, net
3,045.4a
2,911.8a
Goodwill, net
6,369.7a
6,142.5a
Intangible assets, net
3,488.9a
3,342a
Joint venture partnerships and equity method investments
16.3a
26.9a
Other assets, net
652.2a
536.5a
Total assets
18,379a
16,725.1a
Liabilities and shareholders' equity
Current liabilities
Accounts payable
875.8a
827.5a
Accrued expenses and other
871.2a
804a
Unearned revenue
392.2a
421.7a
Short-term operating lease liabilities
184.6a
165.8a
Short-term finance lease liabilities
6.1a
6.4a
Short-term borrowings and current portion of long-term debt
1,000.3a
999.8a
Total current liabilities
3,330.2a
3,225.2a
Long-term debt, less current portion
5,331.2a
4,054.7a
Operating lease liabilities
676.3a
648.9a
Financing lease liabilities
74.3a
78.6a
Deferred income taxes and other tax liabilities
383.1a
417.9a
Other liabilities
517.4a
409.3a
Total liabilities
10,312.5a
8,834.6a
Noncontrolling interest
14.3a
15.5a
Shareholders' equity
Common stock, 83.4 and 83.9 shares outstanding at December 31, 2024, and 2023, respectively
7.6a
7.7a
Additional paid-in capital
2.8a
38.4a
Retained earnings
8,303.4a
7,888.2a
Accumulated other comprehensive loss
-261.6a
-59.3a
Total shareholders' equity
8,052.2a
7,875a
Total liabilities and shareholders' equity
18,379a
16,725.1a
Download Data

Verified Sources Behind Labcorp’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Labcorp’s data sources below and access millions more through our Disclosure Search.

a. Labcorp's 10-K 2024
a. Labcorp's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?